In individuals with class 3 obesity, obesity itself may be as strong as prediabetes or type 2 diabetes (T2D) in driving the risk of peripheral neuropathy (PN), a study in the Journal of Clinical Endocrinology and Metabolism suggests.
The study analyzed plasma global metabolomics and targeted lipidomics in participants with obesity who either had PN (n=44) or didn’t have PN (n=44). These participants were matched for glycemic status and compared with a lean, non-neuropathic control participants … read more